Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Some vaccines might rarely cause hair loss, more research is needed.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Physical activity, height, and smoking affect prostate cancer risk.

Women with irregular periods have a higher risk of heart disease.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

People with hidradenitis suppurativa have a higher risk of heart attacks and strokes.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.